Literature DB >> 1563099

Immunization of mice with the antigen A60 of Mycobacterium bovis BCG.

R D Hubbard1, C M Flory, F M Collins, C Cocito.   

Abstract

Antigen 60 (A60) is a thermostable component of the cytoplasm of Mycobacterium tuberculosis and BCG which can be fractionated into at least 15 protein bands when analysed by Western blot. Normal B6D2 mice were immunized subcutaneously with 20 micrograms of the A60 protein suspended in Freund's incomplete adjuvant (FIA) or in saline. Three weeks later the mice received a second dose of vaccine followed 2 weeks later by an aerogenic challenge with approximately 10(3) CFU of M. tuberculosis Erdman. The mice receiving the adjuvanted A60 showed a significant reduction (P less than 0.05) in the number of viable organisms recovered from the lungs and the spleen 3 weeks after challenge. However, this response was less than that seen in BCG vaccinated controls.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1563099      PMCID: PMC1554356          DOI: 10.1111/j.1365-2249.1992.tb03051.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

Review 1.  Serology of mycobacteria: characterization of antigens recognized by monoclonal antibodies.

Authors:  D B Young; A Mehlert
Journal:  Rev Infect Dis       Date:  1989 Mar-Apr

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Production and assay of antibodies against one antigenic component of Mycobacterium bovis BCG.

Authors:  M Harboe; O Closs; K Svindahl; J Deverill
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

Review 4.  Current status of immunological adjuvants.

Authors:  H S Warren; F R Vogel; L A Chedid
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

5.  The antigens of Mycobacterium bovis, strain BCG, studied by crossed immunoelectrophoresis: a reference system.

Authors:  O Closs; M Harboe; N H Axelsen; K Bunch-Christensen; M Magnusson
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

6.  Mycobacterial proliferation in macrophages is prevented by incubation with lymphocytes activated in vitro with a mycobacterial antigen complex.

Authors:  A Beschin; L Brijs; P De Baetselier; C Cocito
Journal:  Eur J Immunol       Date:  1991-03       Impact factor: 5.532

7.  Chemical composition of antigen 60 from Mycobacterium bovis BCG.

Authors:  I Fabre; O L'Homme; M Bruneteau; G Michel; C Cocito
Journal:  Scand J Immunol       Date:  1986-11       Impact factor: 3.487

8.  Antibodies against BCG antigen 60 in mycobacterial infection.

Authors:  M Harboe; O Closs; B Bjorvatn; G Bjune
Journal:  Br Med J       Date:  1977-08-13

9.  Immunological properties of antigen 60 of BCG. Induction of humoral and cellular immune reactions.

Authors:  C Cocito; M C Baelden; C Benoit
Journal:  Scand J Immunol       Date:  1987-06       Impact factor: 3.487

10.  Protection to mice afforded by BCG vaccines against an aerogenic challenge by three mycobacteria of decreasing virulence.

Authors:  F M Collins
Journal:  Tubercle       Date:  1985-12
View more
  8 in total

1.  A single dose of a DNA vaccine encoding apa coencapsulated with 6,6'-trehalose dimycolate in microspheres confers long-term protection against tuberculosis in Mycobacterium bovis BCG-primed mice.

Authors:  Dyego Carlétti; Denise Morais da Fonseca; Ana Flávia Gembre; Ana Paula Masson; Lívia Weijenborg Campos; Luciana C C Leite; Andréa Rodrigues Pires; Joseli Lannes-Vieira; Célio Lopes Silva; Vânia Luiza Deperon Bonato; Cynthia Horn
Journal:  Clin Vaccine Immunol       Date:  2013-06-05

2.  Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis.

Authors:  M K Hondalus; S Bardarov; R Russell; J Chan; W R Jacobs; B R Bloom
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

3.  In vitro analysis of cancer prevention by a mycobacterial antigen complex and of cancer-promoted inhibition of immune reactions.

Authors:  H Maes; C Cocito
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

4.  A single mycobacterial protein (hsp 65) expressed by a transgenic antigen-presenting cell vaccinates mice against tuberculosis.

Authors:  C L Silva; D B Lowrie
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

5.  Comparative cutaneous testing with purified protein derivative and the antigen complex A60 in vaccinated subjects and tuberculosis patients.

Authors:  Y L Zou; J D Zhang; M H Chen; G Q Shi; C Cocito
Journal:  Med Microbiol Immunol       Date:  1995-05       Impact factor: 3.402

6.  Comparison between bacillus Calmette-Guérin and the A60 mycobacterial antigen complex used as cancer-preventive immunotherapies.

Authors:  H Maes; H Taper; C Cocito
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

7.  Immunological analysis of the components of the antigen complex A60 of Mycobacterium bovis BCG.

Authors:  C Coetsier; M C Baelden; M Coene; C Cocito
Journal:  Clin Diagn Lab Immunol       Date:  1994-03

8.  Proteomic Analysis of Antigen 60 Complex of M. bovis Bacillus Calmette-Guérin Reveals Presence of Extracellular Vesicle Proteins and Predicted Functional Interactions.

Authors:  Khayriyyah Mohd Hanafiah; Norsyahida Arifin; Paul R Sanders; Nurulhasanah Othman; Mary L Garcia; David A Anderson
Journal:  Vaccines (Basel)       Date:  2019-08-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.